目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market segmentation
1.1.1 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’S internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.6 List of primary sources
1.4 Information or data analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country - wise market estimation using bottom - up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Abbreviations
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.11.3 Objective 3
1.11.4 Objective 4

Chapter 2 Executive Summary
2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Regulatory framework
3.3 Penetration and Growth Prospect Mapping
3.4 Pipeline Analysis, by Phase
3.4.1 Key upcoming products
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.2 Market restraint analysis
3.6 PESTEL Analysis
3.7 Quality Analysis of the market based route of administration
3.7.1 Intravitreal
3.7.2 Others
3.8 Epidemiology Analysis
3.9 Unmet Need Analysis

Chapter 4 Global Age - Related Macular DegenerationMarket - Segment Analysis, By Product, 2018 - 2030 (USD Million), Patient Share (%)
4.1 Global Age - Related Macular DegenerationMarket: Product Movement Analysis
4.2 Eylea
4.2.1 Eyleaage - related macular degeneration market estimates and forecast, 2018 - 2030 (USD Million), Patient Share (%)
4.3 Lucentis
4.3.1 Lucentisage - related macular degeneration market estimates and forecast, 2018 - 2030 (USD Million), Patient Share (%)
4.4 Beovu
4.4.1 Beovuage - related macular degeneration market estimates and forecast, 2018 - 2030 (USD Million), Patient Share (%)
4.5 Others
4.5.1 Othersage - related macular degeneration market estimates and forecast, 2018 - 2030 (USD Million), Patient Share (%)

Chapter 5 Global Age - Related Macular DegenerationMarket - Segment Analysis, by Disease Type, 2018 - 2030 (USD Million)
5.1 Global Age - Related Macular DegenerationMarket: Disease Type Movement Analysis
5.2 Dry AMD
5.2.1 Dry AMD market estimates and forecast, 2018 - 2030 (USD Million)
5.3 Wet AMD
5.3.1 Wet AMD market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Global Age - Related Macular DegenerationMarket - Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)
6.1 Global Age - Related Macular DegenerationMarket: Distribution Channel Movement Analysis
6.2 Hospital Pharmacy
6.2.1 Hospital Pharmacymarket estimates and forecast, 2018 - 2030 (USD Million)
6.3 Specialty Pharmacy
6.3.1 Specialty Pharmacymarket estimates and forecast, 2018 - 2030 (USD Million)
6.4 Online Pharmacy
6.4.1 Online Pharmacy market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Age - Related Macular DegenerationMarket: Segment Analysis, by Region, 2018 - 2030 (USD Million)
7.1 Age - Related Macular DegenerationMarket: Regional Movement Analysis
7.1.1 North America
7.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
7.1.1.2 U.S.
7.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
7.1.1.3 Canada
7.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2 Europe
7.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.2 U.K.
7.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.3 Germany
7.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.4 France
7.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.5 Spain
7.1.2.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.6 Italy
7.1.2.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3 Asia Pacific
7.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.2 Japan
7.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.3 China
7.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.4 India
7.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.5 Australia
7.1.3.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.5 South Korea
7.1.3.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4 Latin America
7.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.2 Brazil
7.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.3 Mexico
7.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.4 Argentina
7.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5 Middle East & Africa
7.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.2 South Africa
7.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.3 Saudi Arabia
7.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.5 United Arab Emirate
7.1.5.5.1 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Global Age - Related Macular DegenerationMarket: Competitive Analysis
8.1 Recent Developments and Impact Analysis, by Key Market Participants
8.1.1 Major deals & strategic alliances analysis
8.1.1.1 New Product Launches
8.1.1.2 Mergers and Acquisitions
8.1.1.3 Partnerships & Agreements
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.2.3 Emerging Players
8.2.4 Heat Map Analysis
8.3 Company Market Position Analysis
8.4 Vendor Landscape
8.4.1 List of Key Distributors and Channel Partners
8.4.2 List of Potential End Users
8.4.3 Key Company Market Share Analysis, 2021
8.5 Company Market Share, 2021
8.5.1 Competitive Dashboard Analysis
8.6 Private Companies
8.6.1 List of Key Emerging Companies
8.6.2 Regional Network Map
8.7 Company Profiles
8.7.1 F. Hoffmann - La Roche Ltd.
8.7.1.1 Company overview
8.7.1.2 Financial performance
8.7.1.3 Product benchmarking
8.7.1.4 Strategic initiatives
8.7.2 Novartis AG
8.7.2.1 Company overview
8.7.2.2 Financial performance
8.7.2.3 Product benchmarking
8.7.2.4 Strategic initiatives
8.7.3 Bayer AG
8.7.3.1 Company overview
8.7.3.2 Financial performance
8.7.3.3 Product benchmarking
8.7.3.4 Strategic initiatives
8.7.4 Pfizer Inc.
8.7.4.1 Company overview
8.7.4.2 Financial performance
8.7.4.3 Product benchmarking
8.7.4.4 Strategic initiatives
8.7.5 Bausch Health Companies Inc.
8.7.5.1 Company overview
8.7.5.2 Financial performance
8.7.5.3 Product benchmarking
8.7.5.4 Strategic initiatives
8.7.6 Regeneron Pharmaceuticals Inc.
8.7.6.1 Company overview
8.7.6.2 Product benchmarking
8.7.6.3 Strategic initiatives
8.7.7 Amgen Inc.
8.7.7.1 Company overview
8.7.7.2 Financial performance
8.7.7.3 Product benchmarking
8.7.8 Biogen
8.7.8.1 Company overview
8.7.8.2 Financial performance
8.7.8.3 Product benchmarking
8.7.8.4 Strategic initiatives
8.7.9 Samsung Bioepis
8.7.9.1 Company overview
8.7.9.2 Financial performance
8.7.9.3 Product benchmarking
8.7.9.4 Strategic initiatives

List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Age-Related Macular DegenerationMarket, By Region, 2018 - 2030 (USD Million)
Table 4 Global Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 5 Global Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 6 GlobalAge-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 7 North America Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 8 North America Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 9 North America Age-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 10 U.S. Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 11 U.S. Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 12 U.S.Age-Related Macular DegenerationMarket, By Route of Administration, 2018 - 2030 (USD Million)
Table 13 Canada Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 14 Canada Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 15 Canada Age-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Europe Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 17 Europe Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 18 Europe Age-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 19 Germany Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 20 Germany Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 21 Germany Age-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 22 U.K. Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 23 U.K. Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 24 U.K.Age-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 25 France Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 26 France Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 27 France Age-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 28 Italy Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 29 Italy Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 30 ItalyAge-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 31 Spain Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 32 Spain Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 33 SpainAge-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 34 Asia Pacific Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 35 Asia Pacific Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 36 Asia PacificAge-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 37 Japan Age-Related Macular DegenerationMarket, By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 38 Japan Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 39 JapanAge-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 40 China Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 41 China Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 42 China Age-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 43 India Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 44 India Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 45 India Age-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 46 South Korea Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 47 South Korea Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 48 South Korea Age-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 49 Australia Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 50 Australia Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 51 Australia Age-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 52 Latin America Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 53 Latin America Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 54 Latin America Age-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 55 Brazil Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 56 Brazil Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 57 BrazilAge-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 58 Mexico Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 59 Mexico Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 60 MexicoAge-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 61 Argentina Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 62 Argentina Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 63 ArgentinaAge-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 64 Middle East & Africa Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 65 Middle East & Africa Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 66 Middle East & Africa Age-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 67 Saudi Arabia Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 68 Saudi Arabia Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 69 Saudi Arabia Age-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 70 South Africa Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 71 South Africa Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 72 South Africa Age-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)
Table 73 UAE Age-Related Macular DegenerationMarket,By Product, 2018 - 2030 (USD Million) (Patient Share in %)
Table 74 UAE Age-Related Macular DegenerationMarket, By Disease Type, 2018 - 2030 (USD Million)
Table 75 UAEAge-Related Macular DegenerationMarket, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Age-Related Macular Degenerationmarket segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Age-Related Macular Degenerationmarket snapshot
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook, revenue, 2021, (USD Million)
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Age related macular degenerationmarket driver impact
Fig. 14 Age related macular degenerationmarket restraint impact
Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 16 Industry Analysis - Porter’s
Fig. 17 Strategy mapping
Fig. 18 Age-Related Macular Degenerationmarket: Product outlook and key takeaways
Fig. 19 Age-Related Macular Degenerationmarket: Product movement analysis & market share 2021 & 2030
Fig. 20 Eyleaage Related Macular Degenerationmarket estimates and forecast, 2018 - 2030 (USD Million) (Patient Share in %)
Fig. 21 Lucentisage Related Macular Degenerationmarket estimates and forecast, 2018 - 2030 (USD Million)(Patient Share in %)
Fig. 22 Beovu age Related Macular Degeneration market estimates and forecast, 2018 - 2030 (USD Million)(Patient Share in %)
Fig. 23 Others age Related Macular Degeneration market estimates and forecast, 2018 - 2030 (USD Million)(Patient Share in %)
Fig. 24 Age-Related Macular Degenerationmarket: Disease type outlook and key takeaways
Fig. 25 Age-Related Macular Degenerationmarket: Disease Type movement analysis & market share 2021 & 2030
Fig. 26 Dry AMD market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Wet AMD market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Age-Related Macular Degenerationmarket: Distribution channel movement analysis & market share 2021 & 2030
Fig. 29 Hospital Pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Specialty Pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Online Pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Opioids: Regional outlook and key takeaways
Fig. 33 Regional outlook, 2021 & 2030
Fig. 34 North America
Fig. 35 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 U.S.
Fig. 37 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Canada
Fig. 39 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Europe
Fig. 41 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 U.K.
Fig. 43 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Germany
Fig. 45 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 France
Fig. 47 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Italy
Fig. 49 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Spain
Fig. 51 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Asia Pacific
Fig. 53 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Japan
Fig. 55 Japan market estimates and forecast, 2018 - 2030(USD Million)
Fig. 56 China
Fig. 57 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 India
Fig. 59 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 South Korea
Fig. 61 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Australia
Fig. 63 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Latin America
Fig. 65 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Brazil
Fig. 67 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Mexico
Fig. 69 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Argentina
Fig. 71 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Middle East & Africa
Fig. 73 MEA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 South Africa
Fig. 75 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Saudi Arabia
Fig. 77 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 UAE
Fig. 79 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Market differentiators
Fig. 81 Key company market share analysis, 2021
Fig. 82 Company market position analysis
Fig. 83 Competitive dashboard analysis
Fig. 84 Regional network map